Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular Carcinoma
Clinical trial NCT05631613 · UNKNOWN
Trial details
- NCT number
- NCT05631613
- Sponsor
- Zhongda Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-28
- Primary completion
- 2023-03-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.